A carregar...

Sera from Diabetics does not Alter the Effect of mTOR Inhibition on Smooth Muscle Cell Proliferation

Clinical studies of drug eluting stents delivering the mammalian Target of Rapamycin (mTOR) inhibitor, rapamycin (Sirolimus), have demonstrated a reduced efficacy for these devices in diabetic patients, which suggests the mTOR pathway may cease to be dominant in mediating the vascular response to in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moss, Stephanie C., Lightell, Daniel, Deichmann, Richard E., Woods, T. Cooper
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2891793/
https://ncbi.nlm.nih.gov/pubmed/19129735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0b013e318195b588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!